InGeneron is a clinical-stage biotechnology company developing novel, safe, and evidence-based cell therapies. We are setting new therapeutic standards by enabling minimally invasive treatments that unlock the healing potential of each patient’s own regenerative cells processed at the point of care for same-day treatment. We currently focus on helping patients impacted by orthopedic conditions and are conducting several clinical trials to validate our technology as a disease-modifying treatment. Based on more than 20 years of research, InGeneron is dedicated to developing therapies supported by clinical evidence and approved by the FDA.
View Top Employees from InGeneronWebsite | http://www.ingeneron.com |
Revenue | $4 million |
Funding | $26.6 million |
Employees | 23 (22 on RocketReach) |
Founded | 2006 |
Address | 8205 El Rio St., Houston, Texas 77030, US |
Phone | (713) 440-9900 |
Technologies |
JavaScript,
HTML,
PHP
+22 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Alternative Medicine, Business Services, Health Care, Biotechnology, Science and Engineering, Therapeutics |
Web Rank | 7 Million |
Keywords | Ingeneron, Biomedical Companies In Houston, Biotech Companies In Houston, Two Entity Structure |
Competitors | Regeneus Ltd, SQZ Biotechnologies, Sernova Corp., VIDEREGEN LIMITED, ViaCyte |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies |
Looking for a particular InGeneron employee's phone or email?
The InGeneron annual revenue was $4 million in 2024.
Fabian Alt is the CFO of InGeneron.
22 people are employed at InGeneron.
InGeneron is based in Houston, Texas.
The NAICS codes for InGeneron are [54171, 5417, 541713, 54, 541].
The SIC codes for InGeneron are [87, 873].